Related references
Note: Only part of the references are listed.Asciminib: First Approval
Emma D. Deeks
DRUGS (2022)
Small Molecule Kinase Inhibitor Drugs (1995-2021): Medical Indication, Pharmacology, and Synthesis
Cecilia C. Ayala-Aguilera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Strategies for developing DNA-encoded libraries beyond binding assays
Yiran Huang et al.
NATURE CHEMISTRY (2022)
Intrathecal amyloid-beta oligomer administration increases tau phosphorylation in the medial temporal lobe in the African green monkey: A nonhuman primate model of Alzheimer's disease
Dustin R. Wakeman et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)
Recent Advances in the Development of Casein Kinase 1 Inhibitors
Sha-Sha Li et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Landscape of drug-resistance mutations in kinase regulatory hotspots
Pora Kim et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Achieving effective and selective CK1 inhibitors through structure modification
Chenxi Du et al.
FUTURE MEDICINAL CHEMISTRY (2021)
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2021)
FDA Approval Summary: Selumetinib for Plexiform Neurofibroma
Denise Casey et al.
CLINICAL CANCER RESEARCH (2021)
Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry
John P. Guilinger et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases
Benoit de Pins et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2021)
Dangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion
Najma Rachidi et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
Federica Martorana et al.
FRONTIERS IN PHARMACOLOGY (2021)
A current view on Tau protein phosphorylation in Alzheimer's disease
Susanne Wegmann et al.
CURRENT OPINION IN NEUROBIOLOGY (2021)
Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges
Adrian Gironda-Martinez et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
New Promise and Opportunities for Allosteric Kinase Inhibitors
Xiaoyun Lu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
CK1δ over-expressing mice display ADHD-like behaviors, frontostriatal neuronal abnormalities and altered expressions of ADHD-candidate genes
Mingming Zhou et al.
MOLECULAR PSYCHIATRY (2020)
Chemical Control of Mammalian Circadian Behavior through Dual Inhibition of Casein Kinase 1α and δ
Jae Wook Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds
Andreas Luxenburger et al.
MOLECULES (2019)
Novel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau Phosphorylation
Richard Rubenstein et al.
FRONTIERS IN NEUROLOGY (2019)
Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
Ciric To et al.
CANCER DISCOVERY (2019)
Application of a Substrate-Mediated Selection with c-Src Tyrosine Kinase to a DNA-Encoded Chemical Library
Dongwook Kim et al.
MOLECULES (2019)
Akt in cancer: Mediator and more
Sundaramoorthy Revathidevi et al.
SEMINARS IN CANCER BIOLOGY (2019)
Small molecule modulators targeting protein kinase CK1 and CK2
Yuting Qiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Landscape of Atypical and Eukaryotic Protein Kinases
Georgi K. Kanev et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (kcat/Km) of CK1α
Chen Shen et al.
BIOCHEMISTRY (2019)
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Junying Yuan et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Encorafenib and binimetinib for the treatment of BRAF V600E/K-mutated melanoma
A. A. N. Rose
DRUGS OF TODAY (2019)
Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) delta/epsilon
Balbina Garcia-Reyes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Small-Molecule Positive Allosteric Modulators of the β2-Adrenoceptor Isolated from DNA-Encoded Libraries
Seungkirl Ahn et al.
MOLECULAR PHARMACOLOGY (2018)
β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility
Jihee Kim et al.
SKELETAL MUSCLE (2018)
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2017)
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy
Fatima Ardito et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Discovery of a Covalent Kinase Inhibitor from a DNA-Encoded Small Molecule Library x Protein Library Selection
Alix I. Chang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1
Andrew A. Wylie et al.
NATURE (2017)
Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome-lysosome fusion
Victor Bustos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Bidirectional regulation of Aβ levels by Presenilin 1
Victor Bustos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Allosteric beta-blocker isolated from a DNA-encoded small molecule library
Seungkirl Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Up-regulation of casein kinase 1ε is involved in tau pathogenesis in Alzheimer's disease
Caoyi Chen et al.
SCIENTIFIC REPORTS (2017)
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2017)
CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation
Chiara Ianes et al.
AMINO ACIDS (2016)
Allosteric modulators of MEK1: drug design and discovery
Jialin Shang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia et al.
NATURE (2016)
Cobimetinib: First Global Approval
Karly P. Garnock-Jones
DRUGS (2015)
Casein kinase 1α-dependent feedback loop controls autophagy in RAS-driven cancers
Jit Kong Cheong et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
A historical overview of protein kinases and their targeted small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2015)
Allosteric small-molecule kinase inhibitors
Peng Wu et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor
Alexei S. Karpov et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation
Nicole C. Goodwin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies
Christine M. Lovly et al.
CLINICAL CANCER RESEARCH (2014)
Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis
Irene G. Salado et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis
Birgit Schittek et al.
MOLECULAR CANCER (2014)
Selective Knockout of the Casein Kinase 2 in D1 Medium Spiny Neurons Controls Dopaminergic Function
Heike Rebholz et al.
BIOLOGICAL PSYCHIATRY (2013)
Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties
Mathieu Bibian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Trametinib: First Global Approval
Cameron J. M. Wright et al.
DRUGS (2013)
2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε
Joachim Bischof et al.
AMINO ACIDS (2012)
Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization
Ling-Ling Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery and Characterization of Non-ATP Site Inhibitors of the Mitogen Activated Protein (MAP) Kinases
Kenneth M. Comess et al.
ACS CHEMICAL BIOLOGY (2011)
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Curtis A. Thorne et al.
NATURE CHEMICAL BIOLOGY (2010)
Forebrain overexpression of CK1δ leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD
Mingming Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
3,4-Diaryl-isoxazoles and -imidazoles as Potent Dual Inhibitors of p38α Mitogen Activated Protein Kinase and Casein Kinase 1δ
Christian Peifer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions
Lori Badura et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Regulation of Alzheimer's disease amyloid-β formation by casein kinase I
Marc Flajolet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Allosteric inhibitors of Bcr-abl-dependent cell proliferation
FJ Adrián et al.
NATURE CHEMICAL BIOLOGY (2006)
The casein kinase I family:: participation in multiple cellular processes in eukaryotes
U Knippschild et al.
CELLULAR SIGNALLING (2005)
The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development
U Knippschild et al.
ONKOLOGIE (2005)
Pharmacological inhibitors of glycogen synthase kinase 3
L Meijer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total Aβ
L Pastorino et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Structural basis for control by phosphorylation
LN Johnson et al.
CHEMICAL REVIEWS (2001)
Phosphorylation regulates intracellular trafficking of β-secretase
J Walter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Crystal structure of a conformation-selective casein kinase-1 inhibitor
N Mashhoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
